Welcia Holdings Co Ltd
TSE:3141
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 838
3 002
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Welcia Holdings Co Ltd
Total Liabilities & Equity
Welcia Holdings Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Welcia Holdings Co Ltd
TSE:3141
|
Total Liabilities & Equity
ÂĄ621B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
||
Sundrug Co Ltd
TSE:9989
|
Total Liabilities & Equity
ÂĄ416.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Total Liabilities & Equity
ÂĄ556.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Liabilities & Equity
ÂĄ446.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Liabilities & Equity
ÂĄ716.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Liabilities & Equity
ÂĄ485B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
Welcia Holdings Co Ltd
Glance View
Welcia Holdings Co., Ltd. engages in the management of its subsidiaries and group companies which are in the pharmaceutical business. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2008-09-01. The firm is engaged in the provision of the retail business based on a drug store. The firm is mainly engaged in the sale of pharmaceuticals, hygiene care products, baby products, health foods, preparations, cosmetics, household miscellaneous goods and foods.
See Also
What is Welcia Holdings Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
621B
JPY
Based on the financial report for Aug 31, 2024, Welcia Holdings Co Ltd's Total Liabilities & Equity amounts to 621B JPY.
What is Welcia Holdings Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
14%
Over the last year, the Total Liabilities & Equity growth was 12%. The average annual Total Liabilities & Equity growth rates for Welcia Holdings Co Ltd have been 14% over the past three years , 11% over the past five years , and 14% over the past ten years .